BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 19205964)

  • 1. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Music therapy: a novel motivational approach for dually diagnosed patients.
    Ross S; Cidambi I; Dermatis H; Weinstein J; Ziedonis D; Roth S; Galanter M
    J Addict Dis; 2008; 27(1):41-53. PubMed ID: 18551887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major depression and comorbid substance use disorders.
    Davis L; Uezato A; Newell JM; Frazier E
    Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of comorbid bipolar disorder and substance abuse.
    Vornik LA; Brown ES
    J Clin Psychiatry; 2006; 67 Suppl 7():24-30. PubMed ID: 16961421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
    Brunette MF; Mueser KT
    J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
    Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
    J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for PTSD in public-sector mental health settings: the diagnostic utility of the PTSD checklist.
    Grubaugh AL; Elhai JD; Cusack KJ; Wells C; Frueh BC
    Depress Anxiety; 2007; 24(2):124-9. PubMed ID: 16892418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial treatments for bipolar disorders.
    Scott J; Colom F
    Psychiatr Clin North Am; 2005 Jun; 28(2):371-84. PubMed ID: 15826737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review.
    Bradizza CM; Stasiewicz PR; Paas ND
    Clin Psychol Rev; 2006 Mar; 26(2):162-78. PubMed ID: 16406196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use in severe mental illness: self-medication and vulnerability factors.
    Bizzarri JV; Rucci P; Sbrana A; Miniati M; Raimondi F; Ravani L; Massei GJ; Milani F; Milianti M; Massei G; Gonnelli C; Cassano GB
    Psychiatry Res; 2009 Jan; 165(1-2):88-95. PubMed ID: 19054572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of post-booking jail diversion programming for persons with co-occurring disorders.
    Shafer MS; Arthur B; Franczak MJ
    Behav Sci Law; 2004; 22(6):771-85. PubMed ID: 15386559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of comorbid substance and alcohol use disorders to disability among patients in routine psychiatric practice.
    Wilk J; West JC; Rae DS; Regier DA
    Am J Addict; 2006; 15(2):180-5. PubMed ID: 16595357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assertive community treatment in the Netherlands: a randomized controlled trial.
    Sytema S; Wunderink L; Bloemers W; Roorda L; Wiersma D
    Acta Psychiatr Scand; 2007 Aug; 116(2):105-12. PubMed ID: 17650271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.
    Sajatovic M; Friedman SH; Sabharwal J; Bingham CR
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):3-8. PubMed ID: 15018690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders.
    Mueser KT; Crocker AG; Frisman LB; Drake RE; Covell NH; Essock SM
    Schizophr Bull; 2006 Oct; 32(4):626-36. PubMed ID: 16574783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief integrated outpatient dual-diagnosis treatment reduces psychiatric hospitalizations.
    Granholm E; Anthenelli R; Monteiro R; Sevcik J; Stoler M
    Am J Addict; 2003; 12(4):306-13. PubMed ID: 14504023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.